Business & Industry

Halo Pharma becomes dedicated North American drug product CDMO after emerging as a standalone contract development and manufacturing organization focused exclusively on drug product services in North America. The transition follows SK Capital Partners’ decision to divest the active...

Drugmakers turn to AI as a practical way to reduce delays in clinical trials and regulatory submissions, even as artificial intelligence has yet to consistently deliver breakthrough drug molecules, industry executives said at the JP Morgan Healthcare Conference. Executives from...

Seamless Therapeutics has entered a global research collaboration and licensing agreement with Eli Lilly and Company under the Seamless Therapeutics Eli Lilly hearing loss collaboration, focused on developing programmable recombinase-based genetic medicines for hearing loss. The collaboration will unite Seamless...

AstraZeneca has agreed to license experimental obesity and metabolic disease drugs from China’s CSPC Pharmaceutical Group under the AstraZeneca CSPC weight-loss deal, with total potential payments reaching $18.5 billion. The agreement includes $1.2 billion paid upfront, with up to $17.3...

The rapid emergence of interconnected sensors, wearable devices, and remote-control instrumentation is fundamentally changing the landscape of pharmaceutical research. By creating a responsive and data-rich environment, these innovations allow for greater precision in experimental monitoring and a more comprehensive understanding of complex biological systems, paving the way for more effective therapeutic outcomes.

Over more than ten years working in healthcare, medical manufacturing, and life sciences, it’s clear how much the industry has developed and adapted. One of the biggest shifts has been the focus on sustainability. What used to be a...

Bringing a pharmaceutical product to market is hard work. Pre-market regulatory requirements in the United States and the European Union are well established and generally well understood by experienced development teams. And it still years and millions of dollars...